.bmp)
.bmp)
NEW YORK-In a closed-door meeting with House Democrats at their retreat at the posh Kingsmill Golf Resort in Williamsburg Va., President Obama gave his "guarantee" he will sign an executive order overturning President Bush's executive order restricting federal funding for embryonic stem cell research.Obama's reversal of Bush's policy comes in the face of scientific evidence that more than two decades of embryonic stem cell research have failed to produce medically valuable results, while adult stem cell research has resulted in successful medical treatments for a wide range of illnesses.By using an executive order to approve embryonic stem cell research for human therapeutic uses, the Obama administration plans to bypass congressional discussion and debate, seeking instead to reverse the Bush executive order without introducing any new legislation, the Washington Times reports.Obama appears determined to push the embryonic stem cell political agenda, despite medical concerns that therapeutic results in human medical treatments over decades have proved that adult stem cells and stem cells derived from human placenta produce results, while embryonic stem cells produce tumors hazardous to human health."Most of the media report only 'stem cell' research, not distinguishing between embryonic stem cells and adult stem cells," David Prentice, senior fellow for life sciences at the Family Research Council, told WND."Embryonic stem cell research relies upon the destruction of a young human embryo," he emphasized. "You have to cannibalize a young human life to get embryonic human stem cells, something you do not need to do if you work with adult stem cells."Dr. William R. Prather, RPh, MD, a registered pharmacist as well as a board certified internist and geriatrician, told WND there's a "very good chance we will never get an FDA-approved product from an embryonic source."Prather has decided not to work with any corporation involved with embryonic stem cell research, preferring instead to devote his energies to companies advancing adult stem cell therapies.He currently services as senior vice president for corporate development for Pluristem Therapeutics Inc., a publicly-listed bio-therapeutics company dedicated to commercial medical applications of adult stem cell therapies applied to a variety of severe nerve and autoimmune disorders where current medical therapies are unavailable or inadequate."In order to be defined as an embryonic stem cell, those cells by definition form tumors, called teratoma tumors," Prather said."Because embryonic stem cells are pluripotent, embryonic stem cells able capable of developing into all the rest of the tissue that comprise the human body," he stressed. "But being pluripotent is a double-edged sword. Those favoring embryonic stem cell research want to use embryonic stem cells because they are pluripotent, but that is also the reason not to use embryonic stem cells...."By Jerome R. Corsi
To read more go to:
As in the days of Noah....
